z-logo
open-access-imgOpen Access
The importance of intermediate-dose Valacyclovir in primary CMV prophylaxis after Allogeneic-stem cell transplantation, and the advantages of step-wise pre-emptive treatment in CMV reactivation
Author(s) -
Osman Kara,
Sinem Acar,
Tayfun Elibol
Publication year - 2022
Publication title -
medical science and discovery
Language(s) - English
Resource type - Journals
ISSN - 2148-6832
DOI - 10.36472/msd.v9i6.743
Subject(s) - medicine , valganciclovir , ganciclovir , cytomegalovirus , transplantation , cidofovir , foscarnet , autologous stem cell transplantation , gastroenterology , surgery , human cytomegalovirus , immunology , human immunodeficiency virus (hiv) , herpesviridae , virus , viral disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom